Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
01:16:57 2026-10-19 pm EDT
|
5-day change | 1st Jan Change | ||
| 353.99 USD | +0.08% |
|
-2.97% | +16.71% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 9,510 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 15.81% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 8,761 | 8,545 | 8,403 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | 11.26% | -2.47% | -1.65% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 42.5x | 41.6x | 41.9x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | - | - | - |
| PEG | - | - | - | -0x | -0x | -0.6x | 18.22x | -59.43x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.7x | 3.62x | 3.58x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 3.41x | 3.26x | 3.17x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 22.1x | 20.9x | 19.4x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 30x | 27.1x | 25.1x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 27.9x | 29x | 25.4x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 3.58% | 3.45% | 3.94% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,569 | 2,624 | 2,654 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 395.8 | 408.8 | 432.6 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 292 | 315.4 | 334.4 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 353.70 | 353.70 | 353.70 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,738 | - | - |
| Announcement Date | 2/10/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 42.51x | 3.41x | 22.13x | - | 9.51B | ||
| 30.95x | 4.09x | 15.82x | 2.45% | 181B | ||
| 20.26x | 3.52x | 12.59x | 2.99% | 116B | ||
| 22.98x | 4.5x | 15.69x | 1.22% | 113B | ||
| 27.35x | 2.68x | 10.75x | 2.64% | 79.83B | ||
| 18.7x | 0.22x | 13.49x | 0.7% | 65.06B | ||
| 31.17x | 7.75x | 19.98x | 1.28% | 54.35B | ||
| 36.95x | 3.53x | 12.1x | 2.05% | 52.23B | ||
| 37.95x | 9.42x | 26.36x | -.--% | 44.15B | ||
| 34.57x | 6.06x | 19.03x | -.--% | 32.47B | ||
| Average | 30.34x | 4.52x | 16.79x | 1.48% | 74.81B | |
| Weighted average by Cap. | 27.79x | 4.19x | 15.44x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















